Skip to main content
Top
Published in: Hepatology International 2/2020

01-03-2020 | Splenectomy | Editorial

Long-term outcome of pediatric non-cirrhotic portal fibrosis from the viewpoint of endoscopic profile

Authors: Kohei Kotani, Norifumi Kawada

Published in: Hepatology International | Issue 2/2020

Login to get access

Excerpt

Non-cirrhotic portal fibrosis (NCPF) presents with non-cirrhotic portal hypertension characterized by moderate to severe splenomegaly, evidence of varices and/or collaterals, patent splenoportal axis and hepatic veins, normal liver functions, normal or near-normal hepatic venous pressure gradient (HVPG), and no evidence of cirrhosis or parenchymal injury in the liver histology [1]. The disease occurs worldwide but is common in socioeconomically disadvantaged countries, including India, and patients are generally young in their third and fourth decades of life. A similar disease group called idiopathic portal hypertension (IPH) in Japan has female preponderance and presents in the fourth and fifth decades of life [2]. This condition is known as idiopathic non-cirrhotic portal hypertension (INCPH) in the western countries [3]. …
Literature
1.
go back to reference Sarin SK, Kumar A, Chawla YK, Baijal SS, Dhiman RK, Jafri W, et al. Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment. Hepatol Int 2007;1:398–413CrossRef Sarin SK, Kumar A, Chawla YK, Baijal SS, Dhiman RK, Jafri W, et al. Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment. Hepatol Int 2007;1:398–413CrossRef
2.
go back to reference Ohfuji S, Furuichi Y, Akahoshi T, Kage M, Obara K, Hashizume M, et al. Japanese periodical nationwide epidemiologic survey of aberrant portal hemodynamics. Hepatol Res 2019;49:890–901CrossRef Ohfuji S, Furuichi Y, Akahoshi T, Kage M, Obara K, Hashizume M, et al. Japanese periodical nationwide epidemiologic survey of aberrant portal hemodynamics. Hepatol Res 2019;49:890–901CrossRef
3.
go back to reference Schouten JN, Garcia-Pagan JC, Valla DC, Janssen HL. Idiopathic noncirrhotic portal hypertension. Hepatology 2011;54:1071–1081CrossRef Schouten JN, Garcia-Pagan JC, Valla DC, Janssen HL. Idiopathic noncirrhotic portal hypertension. Hepatology 2011;54:1071–1081CrossRef
4.
go back to reference Khanna R, Sarin SK. Non-cirrhotic portal hypertension - diagnosis and management. J Hepatol 2014;60:421–441CrossRef Khanna R, Sarin SK. Non-cirrhotic portal hypertension - diagnosis and management. J Hepatol 2014;60:421–441CrossRef
5.
go back to reference Sood V, Lal BB, Khanna R, Rawat D, Bihari C, Alam S. Noncirrhotic portal fibrosis in pediatric population. J Pediatr Gastroenterol Nutr 2017;64:748–753CrossRef Sood V, Lal BB, Khanna R, Rawat D, Bihari C, Alam S. Noncirrhotic portal fibrosis in pediatric population. J Pediatr Gastroenterol Nutr 2017;64:748–753CrossRef
6.
go back to reference Prasad D, Sen Sarma M, Yachha SK, Srivastava A, Poddar U. Pediatric non-cirrhotic portal fibrosis: role of endoscopic management in determining long-term outcome. Hepatol Int 2019 (Epub ahead of print) Prasad D, Sen Sarma M, Yachha SK, Srivastava A, Poddar U. Pediatric non-cirrhotic portal fibrosis: role of endoscopic management in determining long-term outcome. Hepatol Int 2019 (Epub ahead of print)
7.
go back to reference Dhiman RK, Chawla Y, Vasishta RK, Kakkar N, Dilawari JB, Trehan MS, et al. Non-cirrhotic portal fibrosis (idiopathic portal hypertension): experience with 151 patients and a review of the literature. J Gastroenterol Hepatol 2002;17:6–16CrossRef Dhiman RK, Chawla Y, Vasishta RK, Kakkar N, Dilawari JB, Trehan MS, et al. Non-cirrhotic portal fibrosis (idiopathic portal hypertension): experience with 151 patients and a review of the literature. J Gastroenterol Hepatol 2002;17:6–16CrossRef
8.
go back to reference Siramolpiwat S, Seijo S, Miquel R, Berzigotti A, Garcia-Criado A, Damell A, et al. Idiopathic portal hypertension: natural history and long-term outcome. Hepatology 2014;59:2276–2785CrossRef Siramolpiwat S, Seijo S, Miquel R, Berzigotti A, Garcia-Criado A, Damell A, et al. Idiopathic portal hypertension: natural history and long-term outcome. Hepatology 2014;59:2276–2785CrossRef
9.
go back to reference Kotani K, Kawabe J, Morikawa H, Akahoshi T, Hashizume M, Shiomi S. Comprehensive screening of gene function and networks by DNA microarray analysis in Japanese patients with idiopathic portal hypertension. Mediators Inflamm 2015;2015:349215CrossRef Kotani K, Kawabe J, Morikawa H, Akahoshi T, Hashizume M, Shiomi S. Comprehensive screening of gene function and networks by DNA microarray analysis in Japanese patients with idiopathic portal hypertension. Mediators Inflamm 2015;2015:349215CrossRef
10.
go back to reference Dabritz J, Worch J, Materna U, Koch B, Koehler G, Duck C, et al. Life-threatening hypersplenism due to idiopathic portal hypertension in early childhood: case report and review of the literature. BMC Gastroenterol 2010;10:122CrossRef Dabritz J, Worch J, Materna U, Koch B, Koehler G, Duck C, et al. Life-threatening hypersplenism due to idiopathic portal hypertension in early childhood: case report and review of the literature. BMC Gastroenterol 2010;10:122CrossRef
Metadata
Title
Long-term outcome of pediatric non-cirrhotic portal fibrosis from the viewpoint of endoscopic profile
Authors
Kohei Kotani
Norifumi Kawada
Publication date
01-03-2020
Publisher
Springer India
Published in
Hepatology International / Issue 2/2020
Print ISSN: 1936-0533
Electronic ISSN: 1936-0541
DOI
https://doi.org/10.1007/s12072-020-10028-y

Other articles of this Issue 2/2020

Hepatology International 2/2020 Go to the issue